Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Preclinical Toxicity of a Siddha Formulation Kandhaga Rasayanam ( KR ) and Its Therapeutic Efficacy in Padarthamarai ( Dermatophytoses ) by an Open Clinical Trial

NCT02238912 is registered in ClinicalTrials.gov with National institute of Siddha as lead sponsor.

NCT NCT02238912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02238912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Preclinical Toxicity of a Siddha Formulation Kandhaga Rasayanam ( KR ) and Its Therapeutic Efficacy in Padarthamarai ( Dermatophytoses ) by an Open Clinical Trial
Lead sponsor
National institute of Siddha
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2012
Completion date
Not reported
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tinea infections such as tinea corporis, tinea cruris, tinea pedis, tinea mannum, tinea barbae, tinea capitis are studied